Koyfin Home > Directory > Health Care > Aduro Biotech > Total Equity

Aduro Biotech Total Equity Chart (ADRO)

Aduro Biotech annual/quarterly Total Equity from 2013 to 2020.
  • Aduro Biotech Total Equity for the quarter ending June 06, 2020 was $47m a -76.00% decrease of -35m year over year
  • Aduro Biotech Total Equity for the last 12 months ending June 06, 2020 was $47m a -76.00% decrease of -35m year over year
  • Aduro Biotech Annual Total Equity for 2019 was $66m a -106.28% decrease of -70m from 2018
  • Aduro Biotech Annual Total Equity for 2018 was $135m a -75.50% decrease of -102m from 2017
  • Aduro Biotech Annual Total Equity for 2017 was $237m a 4.32% increase of 10m from 2016
Other Balance Sheet Metrics:
  • Aduro Biotech Total Assets for the quarter ending December 12, 2018 was $358m a -18.27% decrease of -65m year over year
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
View Chart On Koyfin

Quarterly ADRO Total Equity Data

06/2020$47m
03/2020$60m
12/2019$66m
09/2019$82m
06/2019$101m
03/2019$115m
12/2018$135m
09/2018$158m
06/2018$176m
03/2018$197m

Annual ADRO Total Equity Data

2019$66m
2018$135m
2017$237m
2016$227m
2015$262m
2014$79m
2013$-6m
2012$-4m